Common Contracts
6 similar null contracts by Brain Scientific Inc., Forza Innovations Inc, Guided Therapeutics Inc, Visium Technologies, Inc.
COMMON STOCK PURCHASE WARRANT FORZA INNOVATIONS INC.Forza Innovations Inc • September 29th, 2022 • Metal doors, sash, frames, moldings & trim • Delaware
This COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the promissory note in the principal amount of $290,000.00 to the Holder (as defined below) of even date) (the “Note”), MAST HILL FUND, L.P., a Delaware limited partnership (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from FORZA INNOVATIONS INC., a Wyoming corporation (the “Company”), 100,000,000 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated September 19, 2022, by and among the Company and the
COMMON STOCK PURCHASE WARRANT FORZA INNOVATIONS INC.Forza Innovations Inc • September 29th, 2022 • Metal doors, sash, frames, moldings & trim • Delaware
This COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the promissory note in the principal amount of $290,000.00 to the Holder (as defined below) of even date) (the “Note”), MAST HILL FUND, L.P., a Delaware limited partnership (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from FORZA INNOVATIONS INC., a Wyoming corporation (the “Company”), 100,000,000 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated September 19, 2022, by and among the Company and the
COMMON STOCK PURCHASE WARRANTVisium Technologies, Inc. • February 16th, 2021 • Services-computer programming services • Delaware
This COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the promissory note in the principal amount of $500,000.00 to the Holder (as defined below) of even date) (the “Note”), Labrys Fund, LP, a Delaware limited partnership (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from VISIUM TECHNOLOGIES, INC., a Florida corporation (the “Company”), 12,500,000 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated February 8, 2021, by and among the Company and the Hold
COMMON STOCK PURCHASE WARRANT (WARRANT A) BRAIN SCIENTIFIC INC.Brain Scientific Inc. • December 31st, 2020 • Surgical & medical instruments & apparatus • Nevada
This COMMON STOCK PURCHASE WARRANT (WARRANT A) (the “Warrant”) certifies that, for value received (in connection with the issuance of the $300,000.00 senior secured promissory note to the Holder (as defined below) of even date) (the “Note”), Auctus Fund, LLC, a Delaware limited liability company (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the issuance hereof, to purchase from BRAIN SCIENTIFIC Inc., a Nevada corporation (the “Company”), up to 250,000 shares of Common Stock (as defined below) (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated December 28, 2020, by and among the Com
COMMON STOCK PURCHASE WARRANT (WARRANT B) BRAIN SCIENTIFIC INC.Brain Scientific Inc. • December 31st, 2020 • Surgical & medical instruments & apparatus • Nevada
This COMMON STOCK PURCHASE WARRANT (WARRANT B) (the “Warrant”) certifies that, for value received (in connection with the issuance of the $300,000.00 senior secured promissory note to the Holder (as defined below) of even date) (the “Note”), Auctus Fund, LLC, a Delaware limited liability company (including any permitted and registered assigns, the ”Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the issuance hereof, to purchase from BRAIN SCIENTIFIC Inc., a Nevada corporation (the ”Company”), up to 250,000 shares of Common Stock (as defined below) (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated December 28, 2020, by and among the Com
COMMON STOCK PURCHASE WARRANT GUIDED THERAPEUTICS, INC.Guided Therapeutics Inc • April 20th, 2020 • Electromedical & electrotherapeutic apparatus • Nevada
This COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received (in connection with the issuance of the $700,000.00 senior secured convertible promissory note to the Holder (as defined below) of even date) (the "Note"), Auctus Fund, LLC, a Delaware limited liability company (including any permitted and registered assigns, the "Holder"), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from Guided Therapeutics, Inc., a Delaware corporation (the "Company"), up to 7,500,000 shares of Common Stock (as defined below) (the "Warrant Shares") (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated December 17,2019, by an
